期刊文献+

奎硫平与利培酮治疗精神分裂症效果比较

下载PDF
导出
摘要 奎硫平(思瑞康)是继利培酮(维思通)、奥氮平之后问世的又一新型非典型抗精神病药物。为了探讨其治疗精神分裂症的疗效和安全性,本文作者于2006年9月至2007年3月选择奎硫平治疗精神分裂症并与利培酮进行对照观察,现将结果报道如下:
出处 《中国乡村医药》 2008年第9期25-26,共2页
  • 相关文献

参考文献5

二级参考文献26

  • 1Small JG, Hirsh SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high dose and low double-blind comparison with placebo.Arch Gen Psychiartry, 1997, 54(6) :549.
  • 2Arvanitis LA, Kandel ER. Quetiapine in the treatment of schizophrenia Patient. Biol Psychiatry, 1997, 42(4) :233.
  • 3Goldstein JM, Litwin LG, Sutton EB, et al. Seroquel: electrophysiological profile of a potential atypical antipsychiatry [ J ]. Psychopharmacology, 1993,112: 293-298.
  • 4Hellewell JSE. Kalali AH, Langham SJ, et al. Patient satisfaction and acceptability of long-term treatment with quetiapine[ J]. Int J Psychiatry Clin Pract. 1999.3 : 105-113.
  • 5Peuskens J, Link CK. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia[ J ]. Acta Psychiatr Scand, 1997,96 : 265-273.
  • 6Emsley RA, Raniwalla J, Bailey PJ. el al. A comparison of the effects of quetiapine ( 'seroquel' ) and halopefidol in schizophrenic patients witha history of and a demonstrated, partial response to conventional antipsychotic treatment [ J]. Int Clin Psychopharmacol, 2000. 15: 121-131.
  • 7Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high and low-dose double-blind comparison with placebo[ J]. Arch Gen psychiatry, 1997,54: 549-557.
  • 8Kasper S, Tauscher j, Kufferle B, et al. Dopamine and serotonine-receptor in schizophrenia: results of imaging-studies and implications for pharamacology in sehizophenia. Eur Arch Psychiatry Clin (Neunasci)1999, (Suppl 4) :83-89.
  • 9顾牛范,笪志民.抗精神病新药奎太平[J].上海精神医学,1998,10(2):123-125. 被引量:11
  • 10张晓红,高粉霞.抗精神病药奎的平介绍[J].临床精神医学杂志,2001,11(6):377-377. 被引量:14

共引文献478

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部